Channels

 

Special Offers & Promotions

 

 

Latest News

 

 

View Channel

New Products

 

 

View Channel

Video Presentations

 

 

View Channel

Separation Science

 

 

View Channel

Microscopy & Image Analysis

 

 

View Channel

Laboratory Automation & IT Solutions

 

 

View Channel

 

Merck Introduces MILLIPLEX High Sensitivity Panel for Faster, More Economical Cytokine Assays

publication date: Jan 5, 2017
 | 
author/source: Merck

Product offers smaller sample volumes and four times higher throughput than traditional assays

merckMerck, a leading science and technology company, has launched the MILLIPLEX® MAP Human High Sensitivity cytokine panel for faster and more cost-effective human cytokine assays. The new panel allows researchers to achieve four times higher throughput than traditional assays while using smaller sample sizes.

The new assay is the first 384-well kit for use with the Luminex FLEXMAP 3D®platform. Researchers can now simultaneously measure multiple protein biomarkers in a single sample, collecting up to 366 data points per plate in the same time it would take to run a 96-well plate. The new kit delivers high specificity and sensitivity and requires less than 10 µm of sample.

"The availability of validated 384-well kits is an important new tool for customers with limited sample volumes who require high throughput, specificity and selectivity," said Jason Apter, Head of Research Solutions Strategic Marketing & Innovation, Life Science. "Simply put, researchers with limited sample volumes will get more results, faster."

Rush Medical College's laboratory has been using customized designed 384-well assays on the Luminex FLEXMAP 3D® system for nearly two years. 

"Now that Merck is offering off-the-shelf assay kits, we expect to run even more assays in this format, which will help expedite our research," said Jeffery Borgia, Assistant Professor, Rush Medical College.

Assays help researchers identify and quantify soluble proteins and peptides that play an important role in the immune system and its response to antigens, as well as disease states such as inflammatory disease, allergic reactions, irritable bowel disease, sepsis and cancer.

The new MILLIPLEX® MAP Human High Sensitivity cytokine panels expand Merck's existing portfolio of immunoassays for human cytokines, essential tools for academic centers, contract research organizations and biotech/pharma companies. 


more about merck


 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

 

Today's Picks

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners

 

Exhibitions & Events